Long-term antibody responses to COVAXIN and COVISHIELD vaccines in rheumatoid arthritis patients and healthy control population – A cross-sectional study
RA patients had a decreased antibody response, 1 year after receiving the second dose of the COVID-19 vaccine. Nonetheless, there was no discernible difference in the antispike antibody concentration between the COVISHIELD and COVAXIN vaccination groups. Additionally, immunosuppressive medications significantly impact serological responses to these vaccines.
Authors
- Vijaya Prasanna Parimi (ORCID: https://orcid.org/0000-0002-7834-4845)
- Madhavi Eerike (ORCID: https://orcid.org/0000-0002-2049-8163)
- Anand Pyati (ORCID: https://orcid.org/0000-0003-0897-2309)
Institutions
- All India Institute of Medical Sciences (IN)
- Osmania Medical College (IN)
Publication Details
- Journal
- Journal of Family Medicine and Primary Care
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4103/jfmpc.jfmpc_907_24
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00